Name: Aclaro Emulsion
Indications and Usage
Aclaro® is indicated for the gradual treatment of ultraviolet induced dyschromia and discoloration resulting rom the use of oral contraceptives, pregnancy, hormone replacment therapy, or skin trauma.
Nursing mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when hydroquinone is used by a nursing mother.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Safety and effectiveness in pediatric patients below the age of 12 years have not been established.
Dosage and Administration
No systemic reactions have been reported. Occasional cutaneous hypersensitivity (localized contact dermatitis) may occur, in which case the medication should be discontinued and the physician notified immediately.
Aclaro®(hydroquinone USP 4%) emulsion is available as follows:
1.7 ounce airless pump bottle NDC 68712-003-01
Store at controlled room temperature:15˚ - 25˚ C (59˚ – 77˚ F)
Innocutis Holdings, LLC.
Charleston, SC 29401
1. Denton C., Lerner A.B., and Fitzpatrick T.B. "Inhibition of Melanin Formation by Chemical Agents." Journal of Investigative Dermatology. 1952;18:119 - 135.
2. Jimbow K., Obata H., Pathak M., and Fitzpatrick T.B. "Mechanism of Depigmentation by Hydroquinone." Journal of Investigative Dermatology. 1974;62:436 - 449.
|ACLARO HYDROQUINONE |
|Labeler - Innocutis (071501252)|